We are not currently recruiting patients for any active clinical trials. Our team remains actively involved in clinical research aimed at improving treatment options for equine patients. Our most recent clinical trial evaluated intratumoural tigilanol tiglate as a treatment for equine sarcoids and cutaneous melanomas. The study has now concluded, results have been published and can be viewed via the link below.

BEVA Equine Veterinary Journal 2nd April 2025- Intratumoural tigilanol tiglate in the multicentre treatment of equine sarcoids and cutaneous melanomas

Watch this space for future clinical trial opportunities